{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:15:53Z","timestamp":1754162153021,"version":"3.41.2"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1023\/a:1010622129173","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T22:31:49Z","timestamp":1040596309000},"page":"327-328","source":"Crossref","is-referenced-by-count":5,"title":["Phase II Study of Pyrazoloacridine in Metastatic Renal Cell Carcinoma"],"prefix":"10.1007","volume":"19","author":[{"given":"J. Philip","family":"Kuebler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald W.","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Triozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric H.","family":"Kraut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"338126_CR1","first-page":"683","volume":"4","author":"AA Adjei","year":"1998","unstructured":"Adjei AA, Charron M, Rowinsky EK, Svingen PA, Miller J, Reid JM, Sebolt-Leopold J, Ames MM, Kaufman SH:Effect of pyrazoloacridine (NSC 366140) on DNA topoisomerases I and II.Clin Cancer Res 4:683\u2013691,1998","journal-title":"Clin Cancer Res"},{"key":"338126_CR2","first-page":"4299","volume":"47","author":"JS Sebolt","year":"1987","unstructured":"Sebolt JS, Scavone SV, Pinter CD, Hamelehle KI, VonHoff DD, Jackson RC: Pyrazoloacridines, a new class of anticancer agents with selectivity against solid tumors in vitro.Cancer Res 47:4299\u20134304,1987","journal-title":"Cancer Res"},{"key":"338126_CR3","first-page":"4900","volume":"50","author":"P LoRusso","year":"1990","unstructured":"LoRusso P, Wozniak AJ, Polin L, Capps D, Leopold WR, Werbel LM, Biernat L, Dan ME, Corbett TH: Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice.Cancer Res50: 4900\u20134905,1990","journal-title":"Cancer Res"},{"key":"338126_CR4","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1200\/JCO.1995.13.8.1975","volume":"13","author":"EK Rowinsky","year":"1995","unstructured":"Rowinsky EK, Noe DA, Grochow LB, Sartorious SE, Bowling MK, Chen TL, Lubejko BG, Kaufmann SH, Donehower RC: Phase I and pharmacologic studies of Pyrazoloacridine, a novel DNA intercalating agent, on single-dosing and multiple-dosing schedules.J Clin Onc13:1975\u20131984,1995","journal-title":"J Clin Onc"},{"key":"338126_CR5","volume-title":"Investigator's Handbook: A manual for participants in clinical trials of investigational agents sponsored by DCTD, NCI","author":"National Cancer Institute","year":"1993","unstructured":"National Cancer Institute: Investigator's Handbook: A manual for participants in clinical trials of investigational agents sponsored by DCTD, NCI.Bethesda, MD. National Cancer Institute,1993"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1010622129173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1010622129173\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1010622129173.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T19:58:59Z","timestamp":1753819139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1010622129173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["338126"],"URL":"https:\/\/doi.org\/10.1023\/a:1010622129173","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"type":"print","value":"0167-6997"},{"type":"electronic","value":"1573-0646"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}